The latest price target for GE HealthCare Techs (NASDAQ:GEHC) was reported by Citigroup on December 11, 2025. The analyst firm set a price target for $88.00 expecting GEHC to rise to within 12 months (a possible 4.15% upside). 23 analyst firms have reported ratings in the last year.

The latest analyst rating for GE HealthCare Techs (NASDAQ:GEHC) was provided by Citigroup, and GE HealthCare Techs maintained their neutral rating.

The last upgrade for GE HealthCare Technologies Inc happened on May 5, 2025 when UBS raised their price target to $73. UBS previously had a sell for GE HealthCare Technologies Inc.

The last downgrade for GE HealthCare Technologies Inc happened on October 7, 2025 when Citigroup changed their price target from $93 to $83 for GE HealthCare Technologies Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of GE HealthCare Techs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for GE HealthCare Techs was filed on December 11, 2025 so you should expect the next rating to be made available sometime around December 11, 2026.

While ratings are subjective and will change, the latest GE HealthCare Techs (GEHC) rating was a maintained with a price target of $83.00 to $88.00. The current price GE HealthCare Techs (GEHC) is trading at is $84.49, which is within the analyst’s predicted range.